JP2017516066A - 二次性副甲状腺機能亢進症のリスク因子を決定するためのシステムおよび方法 - Google Patents

二次性副甲状腺機能亢進症のリスク因子を決定するためのシステムおよび方法 Download PDF

Info

Publication number
JP2017516066A
JP2017516066A JP2016549735A JP2016549735A JP2017516066A JP 2017516066 A JP2017516066 A JP 2017516066A JP 2016549735 A JP2016549735 A JP 2016549735A JP 2016549735 A JP2016549735 A JP 2016549735A JP 2017516066 A JP2017516066 A JP 2017516066A
Authority
JP
Japan
Prior art keywords
shpt
patient
risk factor
risk
computer system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016549735A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017516066A5 (enExample
Inventor
アルギュロポウロス，クリストス
クセノス，コンスタンティノス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Inc
Original Assignee
AbbVie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AbbVie Inc filed Critical AbbVie Inc
Publication of JP2017516066A publication Critical patent/JP2017516066A/ja
Publication of JP2017516066A5 publication Critical patent/JP2017516066A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/046—Thyroid disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
JP2016549735A 2014-02-04 2015-02-03 二次性副甲状腺機能亢進症のリスク因子を決定するためのシステムおよび方法 Withdrawn JP2017516066A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461935593P 2014-02-04 2014-02-04
US61/935,593 2014-02-04
US14/612,109 US20150220698A1 (en) 2014-02-04 2015-02-02 Systems and methods for determining secondary hyperparathyroidism risk factors
US14/612,109 2015-02-02
PCT/US2015/014188 WO2015119915A1 (en) 2014-02-04 2015-02-03 Systems and methods for determining secondary hyperparathyroidism risk factors

Publications (2)

Publication Number Publication Date
JP2017516066A true JP2017516066A (ja) 2017-06-15
JP2017516066A5 JP2017516066A5 (enExample) 2018-03-01

Family

ID=53755064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016549735A Withdrawn JP2017516066A (ja) 2014-02-04 2015-02-03 二次性副甲状腺機能亢進症のリスク因子を決定するためのシステムおよび方法

Country Status (5)

Country Link
US (1) US20150220698A1 (enExample)
EP (1) EP3102952A1 (enExample)
JP (1) JP2017516066A (enExample)
HK (1) HK1231557A1 (enExample)
WO (1) WO2015119915A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021192163A (ja) * 2020-06-05 2021-12-16 株式会社コスミックコーポレーション 生体情報評価システム及び生体情報評価プログラム
JP2024527790A (ja) * 2021-07-29 2024-07-26 サイロスコープ インコーポレイテッド 被験者の甲状腺機能異常症を予測するための方法及びシステム

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10796802B1 (en) 2015-05-01 2020-10-06 Cerner Innovations, Inc. Computer decision support for determining surgery candidacy in stage four chronic kidney disease
US10600067B2 (en) * 2016-06-16 2020-03-24 Accenture Global Solutions Limited Demographic based adjustment of data processing decision results
CN117577321A (zh) * 2017-08-08 2024-02-20 费森尤斯医疗保健控股公司 用于治疗和评估慢性肾脏疾病的进程的系统和方法
US11238989B2 (en) * 2017-11-08 2022-02-01 International Business Machines Corporation Personalized risk prediction based on intrinsic and extrinsic factors
EP4115815A4 (en) * 2020-03-27 2023-08-09 TERUMO Kabushiki Kaisha Biological function estimation device and biological function estimation method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021192163A (ja) * 2020-06-05 2021-12-16 株式会社コスミックコーポレーション 生体情報評価システム及び生体情報評価プログラム
JP2024527790A (ja) * 2021-07-29 2024-07-26 サイロスコープ インコーポレイテッド 被験者の甲状腺機能異常症を予測するための方法及びシステム
JP7556660B2 (ja) 2021-07-29 2024-09-26 サイロスコープ インコーポレイテッド 被験者の甲状腺機能異常症を予測するための方法及びシステム

Also Published As

Publication number Publication date
HK1231557A1 (zh) 2017-12-22
US20150220698A1 (en) 2015-08-06
EP3102952A1 (en) 2016-12-14
WO2015119915A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
Chen et al. Association of intraindividual difference in estimated glomerular filtration rate by creatinine vs cystatin C and end-stage kidney disease and mortality
US11664126B2 (en) Clinical predictor based on multiple machine learning models
Maziarz et al. On longitudinal prediction with time-to-event outcome: comparison of modeling options
US20150220698A1 (en) Systems and methods for determining secondary hyperparathyroidism risk factors
JP5681712B2 (ja) 臨床診断プロセスのシグマを求めるためのコンピュータで実施される方法およびシステム
CN110024044A (zh) 用于挖掘医疗数据的系统及方法
US20230080350A1 (en) Methods and Apparatus for Diagnosis of Progressive Kidney Function Decline Using a Machine Learning Model
CN114724716A (zh) 进展为2型糖尿病的风险预测的方法、模型训练及装置
Kadatz et al. Predicting progression in CKD: perspectives and precautions
Hayes et al. Illness severity scores in veterinary medicine: what can we learn?
KR20200135444A (ko) 만성 신장 질환의 위험에 대해 피험자를 스크리닝하기 위한 방법들 및 컴퓨터-구현 방법
US20210406731A1 (en) Network-implemented integrated modeling system for genetic risk estimation
Zheng et al. Adopting nested case–control quota sampling designs for the evaluation of risk markers
US20250182902A1 (en) Systems and methods for predicting outcomes for a lung undergoing an ex vivo lung perfusion
Yu et al. Statistical innovations in diagnostic device evaluation
Azizmalayeri et al. Enhancing quality of care assessments: Managing atypical patients in ICU benchmarking in The Netherlands
US10971267B2 (en) Systems and methods for aggregation of automatically generated laboratory test results
Bahrampour et al. Long-Term Survival of Patient with End-Stage Renal Disease Using Bayesian Mixture Cure Rate Frailty Models
US20250391573A1 (en) Generating a composite result using inflammation data
EP4677626A1 (en) Methods and systems for medical condition risk prediction and prediction triggering
Pretz et al. Longitudinal Assessment of Circulating Tumor DNA: A Proposed Statistical Framework
Bakker Developing cost-effective analytics for healthcare
Pietrobon et al. Life Years Lost and Remaining Life Expectancy: A Patient-Centered Survival Analysis Approach in Oncology Research (Motivated by the Catalan Cohort Study on Metabolic Syndrome and Cancer Prognosis by López-Jiménez et al.)
Wu et al. Quantifying Cognitive Workload in ICU Nursing: A Computational Modeling Approach to ECMO Circuit Priming
DesJardin et al. Pulmonary artery compliance is associated with mortality but lacks predictive utility

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180117

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180117

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20180815